A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTI-CENTRE STUDY EVALUATING THE SAFETY, TOLERABILITY AND EFFICACY OF COMBINATION TREATMENT OF BL-8040 AND G-CSF AS COMPARED TO PLACEBO AND G-CSF FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS FOR AUTOLOGOUS TRANSPLANTATION IN SUBJECTS WITH MULTIPLE MYELOMA ¿ THE GENESIS STUDY

Registry ID

BL-8040.SCM.301

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

BIOLINERX LTD

Last update

2019-09-26

Conditions

• MYELOMA
• HEMATOPOIETIC STEM CELL TRANSPLANT

Related clinical trials

• A RANDOMIZED, PHASE 3, OPEN LABEL STUDY EVALUATING SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF ISATUXIMAB IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN ADULT PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM)
• PHASE 3 MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VIRALYM-M (ALVR105) FOR THE TREATMENT OF PATIENTS WITH VIRUS-ASSOCIATED HEMORRHAGIC CYSTITIS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT
• A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
• PLATELET TRANSFUSIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION - THE PATH PHASE III TRIAL
• NOVEL PULMONARY FUNCTION MEASURES FOR DIAGNOSIS OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN.
• A RANDOMIZED PILOT TRIAL COMPARING ANTI-THYMOCYTE GLOBULIN (ATG) WITH ATG PLUS POST TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) FOR PROPHYLAXIS AGAINST ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE (GVHD) IN MATCHED DONOR HEMATOPOIETIC CELL TRANSPLANTS (HCT)

View on source registry